$5.06Day Range$5.30
Key Statistics
Market Cap
$105.82M
Shares Outstanding
20.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 26, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$5.06
Day High
$5.30
Day Low
$5.06
Volume
66.4K
VWAP
$5.18
Prev Close
$5.03
Transactions
--
Acc. Volume
--
About PolyPid Ltd. Ordinary Shares
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
Identifiers
- CIK
- 0001611842
- Ticker Root
- PYPD
About PolyPid Ltd. Ordinary Shares (PYPD) Stock
PolyPid Ltd. Ordinary Shares (PYPD) closed the 2026-09-18 session at $5.21, up 3.58% versus the previous close (+0.18). The stock opened at $5.06 and traded between $5.06 and $5.30 during that session. Session trading volume was 66K shares. The volume-weighted average price (VWAP) is $5.18.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
PolyPid Ltd. Ordinary Shares has a market capitalization of $105.8 million. PYPD is listed on the XNAS exchange. The company employs approximately 75 people. The recorded listing date is 2020-06-26.
On this page you can find market PYPD stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.